Interclean Shanghai

Segasist launches Crowd-Funding Round for Cloud-Based Quality Assurance in Cancer Treatment

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...
Segasist Technologies, a Canadian software company developing next-generation image contouring platforms for biomedical applications, has launched a crowd funding campaign to bring its software Reconcillio on cloud.
 
Reconcillio is the first technology to provide quality assurance in treatment planning for radiation therapy. The software offers automated consensus contouring of tumor images, which increases the safety, accuracy and efficiency of radiation treatments. These markings, called contours, are crucial for efficient treatment. The more accurate the contours, the higher the success rate of killing cancer cells in a shorter time. Inaccurate contouring can lead to partial tumor radiation and damage to the surrounding healthy tissues.
 
Currently, there is no quality assurance for contouring. Cancer patients have to rely on the knowledge and contouring skills of their doctor. Unfortunately, it is well documented that clinicians, given the same image, generally produce different contours. Depending on the tumor type, size and location, studies have shown that clinicians' contours deviate considerably from each other ranging from 5% up to a frightening 60% difference. This long-standing problem is called "inter-observer variability" and results in suboptimal patient care and a more costly treatment.
 
"So, what is the solution?" asks Hamid Tizhoosh, the CEO of Segasist Technologies, "Ideally, we would have several doctors contour the tumor images of one patient. From this, a 'consensus contour' that reflects the collective knowledge of all the doctors is created to serve as a benchmark for accurate measurements. This approach can drastically reduce the variability and assure greater accuracy in treatment."
 
Reconcilio was designed because no healthcare system can afford such a multi-doctor approach.
"Taking this a step further" adds Tizhoosh, "our intention is to put this technology on the 'cloud' in order to extend the software to a large number of doctors and to cover many cancer cases. Software as a Service (SaaS) will enable any doctor to request 'consensus contours' at any time."
Supporters receive different rewards, among others user/site licenses of Segasist contouring software that they can use themselves or donate to any hospital.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »